Fundraising Fox
Andrew Schiff
InvestorManaging Partner at Aisling Capital · Board director at Aclaris Therapeutics · Board director at Agile Therapeutics · Board director at TransEnterix
New York, New York, United States
Find your path to Andrew
31 people in our graph can introduce you to Andrew.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Katie MacFarlane to introduce you to Andrew
You →Katie · together at Agile Therapeutics →Andrew
Ask Jamie Chen to introduce you to Andrew
You →Jamie · 2 people · together at Agile Therapeutics →Andrew
Ask Sam Okafor to introduce you to Andrew
You →Sam · 3 people · together at TransEnterix →Andrew
Sign up to find every way you can get introduced to Andrew
- Your email: the people you already email who know Andrew
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Andrew
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Schiff, an MD, joined Aisling in 2000 as a Managing Partner. He practiced internal medicine for six years at New York Presbyterian Hospital and remains a Clinical Assistant Professor of Medicine. He holds an MD from Cornell, an MBA from Columbia, and a BS from Brown.
Board director at Aclaris Therapeutics
Intro paths
In turn, Andrew can intro founders to Aclaris Therapeutics's investors below.
Aclaris Therapeutics's investors · 8
Co-founders at Aclaris Therapeutics
Board director at Agile Therapeutics
Intro paths
In turn, Andrew can intro founders to Agile Therapeutics's investors below.
Agile Therapeutics's investors · 3
Board director at TransEnterix
Intro paths
In turn, Andrew can intro founders to TransEnterix's investors below.
Experience
- Aisling Capitalno title
Investments
Investor
Agile TherapeuticsAsensus SurgicalDren BioForge BiologicsMiramar LabsMonte Rosa TherapeuticsPlant Culture SystemsSirion TherapeuticsSkinmedicaZavante TherapeuticsZELTIQ
Per curated public sources.
Colleagues at Aisling Capital
Network3
Investors connected to Andrew in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Andrew Schiff?
- Schiff, an MD, joined Aisling in 2000 as a Managing Partner. He practiced internal medicine for six years at New York Presbyterian Hospital and remains a Clinical Assistant Professor of Medicine. He holds an MD from Cornell, an MBA from Columbia, and a BS from Brown.
- Where does Andrew Schiff work?
- Andrew Schiff is Managing Partner at Aisling Capital and Board director at Aclaris Therapeutics and Board director at Agile Therapeutics and Board director at TransEnterix.
- What companies has Andrew Schiff invested in?
- Investments tracked here include Agile Therapeutics, Asensus Surgical, Dren Bio, Forge Biologics, Miramar Labs, Monte Rosa Therapeutics, Plant Culture Systems, Sirion Therapeutics, Skinmedica, Zavante Therapeutics, ZELTIQ.
Shared employers
Also worked at Aisling Capital8
+ 2 more